• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY S CHAGAS; TRYPANOSOMA CRUZI (E COLI, RECOMBINANT) ANTIGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY S CHAGAS; TRYPANOSOMA CRUZI (E COLI, RECOMBINANT) ANTIGEN Back to Search Results
Catalog Number 06P08-50
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2021
Event Type  malfunction  
Event Description
The customer observed false repeat reactive alinity s chagas results 12 out of 29 donor specimens which confirmed nonreactive by esa confirmatory testing.There results provided were: starting from (b)(6) 2021 alinity chagas= repeat reactive /confirmatory on esa (enzyme strip assay) =nonreactive there was no reported impact to patient management.
 
Manufacturer Narrative
Patient information: no specific donor information was provided.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false repeat reactive alinity s chagas results 12 out of 31 donor specimens which confirmed nonreactive by esa confirmatory testing.The customer provided the following summary of repeat reactive and confirmatory results across several months and reagent lot number.No individual donor results provided or specify the reagent lots in use for the samples the same information was reported across all reagent lots.Starting from (b)(6) 2021 alinity chagas= repeat reactive /confirmatory on esa (enzyme strip assay) = nonreactive there was no reported impact to patient management.
 
Manufacturer Narrative
Additional information provided on 27dec2021: the customer provided the following summary of repeat reactive and confirmatory results across several months and reagent lot number.No individual donor results provided or specify the reagent lots in use for the samples the same information was reported across all reagent lots.Updated b5 section: describe event or problem: information provided on 27dec2021: total donor specimens number changed to 31 from 29.
 
Manufacturer Narrative
The complaint evaluation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, field data history of alinity s chagas reagent, lot number 26408be00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Device history record review did not identify any non-conformances or deviations with the complaint lot and complaint issue.The customer data review for alinity s chagas reagent, lot number 26408be00 was performed.The analysis included initial reactive rates (irr), repeat reactive rates (rrr) and specificity (assuming zero prevalence) across all us customer sites and whole blood (wb) peer sites connected to the abbottlink data retrieval system and using these lots.As the alinity s instruments at the customer site are not connected to abbottlink a historical analysis specific to the customer site could not be performed.A aggregated performance of lot 26408be00 across all customer sites and wb peer sites is within product requirements and comparable to the performance of other lots of the same assay evaluated in the comparison (irr: 0.000 to 0.112%; rrr: 0.000 to 0.110%; specificity: 99.890 to 100.000%).All data review indicating that the reagent performing as expected.A review of the manufacturing documentation did not identify any issues associated with the customer¿s observation.There was no issue with reagent performance identified.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity s chagas reagent, lot number 26408be00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S CHAGAS
Type of Device
TRYPANOSOMA CRUZI (E COLI, RECOMBINANT) ANTIGEN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key12979641
MDR Text Key283971695
Report Number3002809144-2021-00694
Device Sequence Number1
Product Code QHM
UDI-Device Identifier00380740117221
UDI-Public00380740117221
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 03/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/16/2022
Device Catalogue Number06P08-50
Device Lot Number26408BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/22/2021
Initial Date FDA Received12/10/2021
Supplement Dates Manufacturer Received12/27/2021
03/01/2022
Supplement Dates FDA Received01/11/2022
03/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/09/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01, (B)(6)
-
-